Clinical Trial Update: Long-pulsed 1064 nm Nd-YAG Laser Versus TCA 20% in Treatment of Keratosis Pilaris [Phase 4]

View source ↗

Summary

Phase 4 trial comparing long-pulsed 1064 nm Nd-YAG laser to TCA 20% for Keratosis Pilaris has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Keratosis Pilaris

Drugs mentioned

• Nd-YAG laser (long-pulsed 1064 nm) (neodymium-doped yttrium aluminum garnet laser)
• TCA 20% (trichloroacetic acid 20%)

Snippet

Sponsor: Cairo University | Conditions: Keratosis Pilaris | Phase 4 | Status: COMPLETED